BioStock Life Science Spring Summit is one of the Nordic region’s most important platforms for private and listed innovation companies to present their projects to both Swedish and international investors, industry colleagues and potential partners.
Industry experts from Novo Nordisk and Vator securities will also share their thoughts on the steps smaller companies should take before and after an acquisition. The conversations will also touch upon raising capital in the current bear market.
During the packed two-day programme, which can be easily and conveniently followed via this link, the Summit will showcase the great breadth and level of innovation that the Nordic life science sector has to offer.
The event is sponsored by Nasdaq Nordic.
Programme
| Tuesday, May 30 | Wednesday, May 31 |
| 10.00 Carbiotix | 10.00 BioInvent |
| 10.20 Prolight Diagnostics | 10.20 Dicot |
| 10.40 Lipum | 10.40 WntResearch |
| 11.00 Expert Insights: Novo Nordisk | 11.00 Bioservo Technologies |
| 11.20 Cereno Scientific | 11.20 Expert Insights: Vator Securities |
| 11.40 Circio | 11.30 Elicera Therapeutics |
| 12.00 Annexin Pharmaceuticals | 11.50 AcuCort |
| 12.20 Ziccum | 12.10 Initiator Pharma |
| 12.40 Colzyx | 12.30 BioArctic |
| 13.00 SynAct Pharma | 12.50 Aptahem |
| 13.20 Pharmacolog | 13.10 AdjuTec Pharma |
| 13.40 Arcede Pharma | 13.30 Suturion |
| 13.33 Stardots | |
| 13.36 Omnio | |
| 13.39 Uptake Bio |
Expert Insights: Big Pharma’s perspective on M&A and integration
| Anna Gran, Associate Director Corporate Integration at Novo Nordisk, gives her view on how a smaller company should prepare for acquisitions and for a life after the agreement is in place.
11.00 am, Tuesday 30 May.
|
 |
Expert Insights: Strategies for raising capital in a bear market
|
Jonas Ribbelöv, Managing Partner at Vator Securities, discusses different strategies for raising capital in a challenging market climate.
11.20 am, Wednesday 31 May
|
 |
